Skip to main content

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
Cancel
×
×
Home
  • Home
Chapter
  • Print publication year: 2010
  • Online publication date: February 2010

Chapter 2 - Myogenic precursor cells

from Section 1 - The scientific basis of muscle disease
Export citation
Recommend this book

Email your librarian or administrator to recommend adding this book to your organisation's collection.

Disorders of Voluntary Muscle
  • Online ISBN: 9780511674747
  • Book DOI: https://doi.org/10.1017/CBO9780511674747
Please enter your name
Please enter a valid email address
Who would you like to send this to *

CAPTCHA *

Skip to the audio challenge
×

References

1. S. Tajbakhsh, M. Buckingham, The birth of muscle progenitor cells in the mouse: spatiotemporal considerations. Curr. Top. Dev. Biol. 48 (2000), 225–268.
2. F. Relaix, D. Montarras, S. Zaffran, et al., Pax3 and Pax7 have distinct and overlapping functions in adult muscle progenitor cells. J. Cell Biol. 172:1 (2006), 91–102.
3. M. Buckingham, F. Relaix, The role of Pax genes in the development of tissues and organs: Pax3 and Pax7 regulate muscle progenitor cell functions. Annu. Rev. Cell Dev. Biol. 23 (2007), 645–673.
4. O. Pourquie, The segmentation clock: converting embryonic time into spatial pattern. Science 301:5631 (2003), 328–330.
5. N. Le Douarin, C. Kalcheim, The Neural Crest. (Cambridge: Cambridge University Press, 1999.)
6. F. Relaix, Skeletal muscle progenitor cells: from embryo to adult. Cell. Mol. Life Sci. 63:11 (2006), 1221–1225.
7. F. Relaix, D. Rocancourt, A. Mansouri, M. Buckingham, A Pax3/Pax7-dependent population of skeletal muscle progenitor cells. Nature 435 (2005), 948–953.
8. M. D. Grounds, Z. Yablonka-Reuveni, Molecular and cell biology of skeletal muscle regeneration. In Molecular and Cell Biology of Muscular Dystrophy, ed. T. A. Partridge. (London: Chapman & Hall, 1993), pp. 210–256.
9. M. D. Grounds, J. White, N. Rosenthal, M. A. Bogoyevitch, The role of stem cells in skeletal and cardiac muscle repair. J. Histochem. Cytochem. 50:5 (2002), 589–610.
10. A. Mauro, Satellite cell of skeletal muscle fibers. J. Biophys. Biochem. Cytol. 9:2 (1961), 493–495.
11. R. Mazanet, C. Franzini-Armstrong, The satellite cell. In Myology, ed. A. G. Engel, B. Q. Banker. (New York: McGraw-Hill, 1986), pp. 285–307.
12. P. Zammit, The muscle satellite cell: the story of a cell on the edge. In Skeletal Muscle Repair and Regeneration, ed. S. Schiaffino, T. Partridge. (New York: Springer, 2008), pp. 45–64.
13. L. Kassar-Duchossoy, B. Gayraud-Morel, D. Gomes, et al., Mrf4 determines skeletal muscle identity in Myf5: Myod double-mutant mice. Nature 431:7007 (2004), 466–471.
14. M. A. Rudnicki, P. N. Schnegelsberg, R. H. Stead, T. Braun, H. H. Arnold, R. Jaenisch, MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75:7 (1993), 1351–1359.
15. P. Seale, L. A. Sabourin, A. Girgis-Gabardo, A. Mansouri, P. Gruss, M. A. Rudnicki, Pax7 is required for the specification of myogenic satellite cells. Cell 102:6 (2000), 777–786.
16. I. M. Conboy, T. A. Rando, The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Dev. Cell 3:3 (2002), 397–409.
17. V. Shinin, B. Gayraud-Morel, D. Gomes, S. Tajbakhsh, Asymmetric division and cosegregation of template DNA strands in adult muscle satellite cells. Nat. Cell Biol. 8:7 (2006), 677–687.
18. J. Dhawan, T. A. Rando, Stem cells in postnatal myogenesis: molecular mechanisms of satellite cell quiescence, activation and replenishment. Trends Cell Biol. 15:12 (2005), 666–673.
19. V. Renault, L. E. Thornell, P. O. Eriksson, G. Butler-Browne, V. Mouly, Regenerative potential of human skeletal muscle during aging. Aging Cell 1:2 (2002), 132–139.
20. P. S. Zammit, T. A. Partridge, Z. Yablonka-Reuveni, The skeletal muscle satellite cell: the stem cell that came in from the cold. J. Histochem. Cytochem. 54:11 (2006), 1177–1191.
21. V. Mouly, A. Aamiri, A. Bigot, et al., The mitotic clock in skeletal muscle regeneration, disease and cell mediated gene therapy. Acta Physiol. Scand. 184:1 (2005), 3–15.
22. C. A. Collins, P. S. Zammit, A. P. Ruiz, J. E. Morgan, T. A. Partridge, A population of myogenic stem cells that survives skeletal muscle aging. Stem Cells 25:4 (2007), 885–894.
23. Z. Yablonka-Reuveni, K. Day, A. Vine, G. Shefer, Defining the transcriptional signature of skeletal muscle stem cells. J. Anim. Sci. 86:14 Suppl (2008), E207–E216.
24. P. O. Mitchell, T. Mills, R. S. O'Connor, et al., Sca-1 negatively regulates proliferation and differentiation of muscle cells. Dev. Biol. 283:1 (2005), 240–252.
25. D. Montarras, J. Morgan, C. Collins, et al., Direct isolation of satellite cells for skeletal muscle regeneration. Science 309 (2005), 2064–2067.
26. C. A. Collins, T. A. Partridge, Self-renewal of the adult skeletal muscle satellite cell. Cell Cycle 4:10 (2005), 1338–1341.
27. M. J. Conboy, A. O. Karasov, T. A. Rando, High incidence of non-random template strand segregation and asymmetric fate determination in dividing stem cells and their progeny. PLoS Biol. 5:5 e102 (2007), 1120–1126.
28. S. Kuang, K. Kuroda, F. Le Grand, M. A. Rudnicki, Asymmetric self-renewal and commitment of satellite stem cells in muscle. Cell 129:5 (2007), 999.
29. G. Cossu, S. Tajbakhsh, Oriented cell divisions and muscle satellite cell heterogeneity. Cell 129:5 (2007), 859–861.
30. P. S. Zammit, J. P. Golding, Y. Nagata, V. Hudon, T. A. Partridge, J. R. Beauchamp, Muscle satellite cells adopt divergent fates: a mechanism for self-renewal?J. Cell Biol. 166:3 (2004), 347–357.
31. Y. Nagata, T. A. Partridge, R. Matsuda, P. S. Zammit, Entry of muscle satellite cells into the cell cycle requires sphingolipid signaling. J. Cell Biol. 174:2 (2006), 245–253.
32. M. D. Grounds, Complexity of extracellular matrix and skeletal muscle regeneration. In Skeletal Muscle Repair and Regeneration, ed. S. Schiaffino, T. A. Partridge. (New York: Springer, 2008), pp. 269–302.
33. Z. Yablonka-Reuveni, G. Shefer, Role of growth factors in directing myogenesis of satellite cells. In Skeletal Muscle Repair and Regeneration, ed. S. Schiaffino, T. Partridge. (New York: Springer, 2008), pp. 45–54.
34. M. D. Grounds, Muscle regeneration: molecular aspects and therapeutic implications. Curr. Opin. Neurol. 12:5 (1999), 535–543.
35. C. Qiao, J. Li, J. Jiang, et al., Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx Mice. Hum. Gene Ther. 19:3 (2008), 241–254.
36. K. Patel, H. Amthor, The function of myostatin and strategies of myostatin blockade – new hope for therapies aimed at promoting growth of skeletal muscle. Neuromusc. Disord. 15 (2005), 117–126.
37. A. Marshall, M. S. Salerno, M. Thomas, et al., Mighty is a novel promyogenic factor in skeletal myogenesis. Exp. Cell Res. 314:5 (2008), 1013–1029.
38. H. Amthor, R. Macharia, R. Navarrete, et al., Lack of myostatin results in excessive muscle growth but impaired force generation. Proc. Natl. Acad. Sci. U. S. A. 104:6 (2007), 1835–1840.
39. T. Shavlakadze, M. D. Grounds, Of bears, frogs, meat, mice and men: insights into the complexity of factors affecting skeletal muscle atrophy/hypertrophy and myogenesis/adipogenesis. BioEssays 28:10 (2006), 994–1009.
40. J. K. McGeachie, M. D. Grounds, Initiation and duration of muscle precursor replication after mild and severe injury to skeletal muscle of mice. Cell Tissue Res. 248 (1987), 125–130.
41. T. A. Robertson, J. M. Papadimitriou, M. D. Grounds, Fusion of myogenic cells to the newly sealed region of damaged myofibres in skeletal muscle regeneration. Neuropathol. Appl. Neurobiol. 19:4 (1993), 350–358.
42. G. Shefer, T. A. Partridge, L. Heslop, J. G. Gross, U. Oron, O. Halevy, Low-energy laser irradiation promotes the survival and cell cycle entry of skeletal muscle satellite cells. J. Cell Sci. 115:Pt 7 (2002), 1461–1469.
43. J. Rantanen, O. Thorsson, P. Wollmer, T. Hurme, H. Kalimo, Effects of therapeutic ultrasound on the regeneration of skeletal myofibers after experimental muscle injury. Am. J. Sports Med. 27:1 (1999), 54–59.
44. C. D. Markert, M. A. Merrick, T. E. Kirby, S. T. Devor, Nonthermal ultrasound and exercise in skeletal muscle regeneration. Arch. Phys. Med. Rehabil. 86:7 (2005), 1304–1310.
45. T. Asano, E. Kaneko, S. Shinozaki, et al., Hyperbaric oxygen induces basic fibroblast growth factor and hepatocyte growth factor expression, and enhances blood perfusion and muscle regeneration in mouse ischemic hind limbs. Circ. J. 71:3 (2007), 405–411.
46. M. D. Grounds, Two-tiered hypotheses for Duchenne muscular dystrophy. Cell Mol. Life Sci. 65:11 (2008), 1621–1625.
47. Z. Yablonka-Reuveni, J. E. Anderson, Satellite cells from dystrophic (mdx) mice display accelerated differentiation in primary cultures and in isolated myofibers. Dev. Dyn. 235:1 (2006), 203–312.
48. S. Decary, C. B. Hamida, V. Mouly, J. P. Barbet, F. Hentati, G. S. Butler-Browne, Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children. Neuromuscul. Disord. 10:2 (2000), 113–120.
49. C. Alexakis, T. Partridge, G. Bou-Gharios, Implication of the satellite cell in dystrophic muscle fibrosis: a self-perpetuating mechanism of collagen overproduction. Am. J. Physiol. Cell Physiol. 293:2 (2007), C661–C669.
50. A. S. Brack, M. J. Conboy, S. Roy, et al., Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 317:5839 (2007), 807–810.
51. P. K. Shireman, The chemokine system in arteriogenesis and hind limb ischemia. J. Vasc. Surg. 45 Suppl A (2007), A48–A56.
52. G. M. Smythe, M. C. Lai, M. D. Grounds, P. Rakoczy, Adeno-associated virus-mediated transfer of vascular endothelial growth factor in skeletal muscle prior to transplantation promotes revascularisation of the regenerating skeletal muscle. Tissue Engineer. 8:5 (2002), 871–891.
53. S. Messina, A. Mazzeo, A. Bitto, et al., VEGF overexpression via adeno-associated virus gene transfer promotes skeletal muscle regeneration and enhances muscle function in mdx mice. FASEB J. 21:13 (2007), 3737–3746.
54. G. R. Adams, Satellite cell proliferation and skeletal muscle hypertrophy. Appl. Physiol. Nutr. Metab. 31:6 (2006), 782–790.
55. J. J. McCarthy, K. A. Esser, Counterpoint: Satellite cell addition is not obligatory for skeletal muscle hypertrophy. J. Appl. Physiol. 103:3 (2007), 1100–1102; discussion 2–3.
56. C. Rehfeldt, In response to Point: Counterpoint: “Satellite cell addition is/is not obligatory for skeletal muscle hypertrophy”. J. Appl. Physiol. 103:3 (2007), 1104.
57. R. S. O'Connor, G. K. Pavlath, J. J. McCarthy, K. A. Esser, Last word on Point: Counterpoint: Satellite cell addition is/is not obligatory for skeletal muscle hypertrophy. J. Appl. Physiol. 103:3 (2007), 1107.
58. M. D. Grounds, H. G. Radley, B. G. Gebski, M. A. Bogoyevitch, T. Shavlakadze, Implications of cross-talk between tumour necrosis factor and insulin-like growth factor-1 signalling in skeletal muscle. Clin. Exp. Pharmacol. Physiol. 35:7 (2008), 846–851.
59. P. G. Arthur, M. D. Grounds, T. Shavlakadze, Oxidative stress as a therapeutic target during muscle wasting: considering the complex interactions. Curr. Opin. Clin. Nutr. Metab. Care 11:4 (2008), 408–416.
60. C. A. Viguie, D. X. Lu, S. K. Huang, H. Rengen, B. M. Carlson, Quantitative study of the effects of long-term denervation on the extensor digitorum longus muscle of the rat. Anat. Rec. 248:3 (1997), 346–354.
61. J. K. McGeachie, M. D. Grounds, Cell proliferation in denervated skeletal muscle: does it provide a pool of potential circulating myoblasts?Bibl. Anat. 29 (1986), 173–193.
62. D. X. Lu, S. K. Huang, B. M. Carlson, Electron microscopic study of long-term denervated rat skeletal muscle. Anat. Rec. 248:3 (1997), 355–365.
63. A. B. Borisov, E. I. Dedkov, B. M. Carlson, Abortive myogenesis in denervated skeletal muscle: differentiative properties of satellite cells, their migration, and block of terminal differentiation. Anat. Embryol. (Berl.) 209:4 (2005), 269–279.
64. K. Doppler, M. Mittelbronn, A. Bornemann, Myogenesis in human denervated muscle biopsies. Muscle Nerve 37:1 (2007), 79–83.
65. A. B. Borisov, E. I. Dedkov, B. M. Carlson, Differentiation of activated satellite cells in denervated muscle following single fusions in situ and in cell culture. Histochem. Cell Biol. 124:1 (2005), 13–23.
66. J. P. Hyatt, R. R. Roy, K. M. Baldwin, A. Wernig, V. R. Edgerton, Activity-unrelated neural control of myogenic factors in a slow muscle. Muscle Nerve 33:1 (2006), 49–60.
67. T. Shavlakadze, M. D. Grounds, Therapeutic interventions for age-related muscle wasting: importance of innervation and exercise for preventing sarcopenia. In Modulating Aging and Longevity, ed. S. Rattan, (The Netherlands: Kluwer Academic, 2003), pp. 139–166.
68. G. S. Lynch, J. D. Schertzer, J. G. Ryall, Therapeutic approaches for muscle wasting disorders. Pharmacol. Ther. 113:3 (2007), 461–487.
69. M. D. Grounds, Age-associated changes in the response of skeletal muscle cells to exercise and regeneration. Ann. N. Y. Acad. Sci. 854 (1998), 78–91.
70. A. Brack, T. A. Rando, Intrinsic changes and extrinsic influences of myogenic stem cell function during aging. Stem Cell Rev. 3:12 (2007), 226–237.
71. G. M. Smythe, T. Shavlakadze, P. Roberts, M. J. Davies, J. K. McGeachie, M. D. Grounds, Age influences the early events of skeletal muscle regeneration: studies of whole muscle grafts transplanted between young (8 weeks) and old (13–21 months) mice. Exp. Gerontol. 43:6 (2008), 550–562.
72. B. M. Carlson, J. A. Faulkner, Muscle transplantation between young and old rats: age of host determines recovery. Am. J. Physiol. 256 (1989), 1262–1266.
73. A. Brack, I. M. Conboy, M. J. Conboy, J. Shen, T. A. Rando, A temporal switch from Notch to Wnt signalling in muscle stem cells is necessary for normal adult myogenesis. Cell Stem Cell 2 (2008), 50–59.
74. P. Menasche, Skeletal myoblasts and cardiac repair. J. Mol. Cell Cardiol. 45:4 (2008), 545–553.
75. J. Stern-Straeter, F. Riedel, G. Bran, K. Hormann, U. R. Goessler, Advances in skeletal muscle tissue engineering. In Vivo 21:3 (2007), 435–444.
76. L. Boldrin, J. E. Morgan, Activating muscle stem cells: therapeutic potential in muscle diseases. Curr. Opin. Neurol. 20:5 (2007), 577–582.
77. J. P. Tremblay, D. Skuk, Another new “super muscle stem cell” leaves unaddressed the real problems of cell therapy for duchenne muscular dystrophy. Mol. Ther. 16:12 (2008), 1907–1909.
78. T. A. Partridge, Stem cell therapies for neuromuscular diseases. Acta Neurol. Belg. 104:4 (2004), 141–147.
79. B. Peault, M. Rudnicki, Y. Torrente, et al., Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol. Ther. 15:5 (2007), 867–877.
80. M. D. Grounds, Skeletal muscle precursors do not arise from bone marrow cells. Cell Tissue Res. 234 (1983), 713–722.
81. G. Ferrari, G. Cusella-De Angelis, M. Coletta, et al., Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279 (1998), 1528–1530.
82. G. Wernig, V. Janzen, R. Schafer, et al., The vast majority of bone-marrow-derived cells integrated into mdx muscle fibers are silent despite long-term engraftment. Proc. Natl. Acad. Sci. U. S. A. 102:33 (2005), 11852–11857.
83. C. Christov, F. Chretien, R. Abou-Khalil, et al., Muscle satellite cells and endothelial cells: close neighbors and privileged partners. Mol. Biol. Cell. 18:4 (2007), 1397–1409.
84. E. Ralston, Z. Lu, N. Biscocho, et al., Blood vessels and desmin control the positioning of nuclei in skeletal muscle fibers. J. Cell. Physiol. 209:3 (2006), 874–882.
85. R. Benchaouir, M. Meregalli, A. Farini, et al., Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice. Cell Stem Cell 1:6 (2007), 646–657.
86. A. Dellavalle, M. Sampaolesi, R. Tonlorenzi, et al., Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat. Cell. Biol. 9:3 (2007), 255–267.
87. K. E. Davies, M. D. Grounds, Treating muscular dystrophy with stem cells?Cell 127:7 (2006), 1304–1306.
88. K. E. Davies, M. D. Grounds, Modified patient stem cells as prelude to autologous treatment of muscular dystrophy. Cell Stem Cell 1:6 (2007), 595–596.
Cancel
Confirm
×